Search

for
Search:

GlossarySunitinib

medication that inhibits enzymes to treat certain cancers

Sunitinib, also known by the brand name Sutent, is a medication used to treat certain types of cancer, including kidney cancer and gastrointestinal stromal tumors. It works by inhibiting multiple protein kinases, which are enzymes involved in the growth and spread of cancer cells.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 96 results

research Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans

73 citations, September 2003 in “Journal of Pharmacology and Experimental Therapeutics”

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

research Adverse Hair Reactions to New Targeted Therapies for Cancer

1 citations, March 2019 in “Actas Dermo-Sifiliográficas”

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

research Sunitinib

February 2012 in “Reactions Weekly”

A woman got male pattern baldness from touching her husband's testosterone gel.

research Advances in the Management of Cutaneous Toxicities of Targeted Therapies

42 citations, April 2012 in “Seminars in Oncology”

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Cutaneous and Mucosal Side Effects of New Anticancer Drugs: EGF-R Inhibitors, Tyrosine Kinase Inhibitors, and Mitotic Spindle Stabilizers

research Cutaneous and Mucosal Side Effects of New Anticancer Drugs: EGF-R Inhibitors, Tyrosine Kinase Inhibitors, and Mitotic Spindle Stabilizers

January 2011

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

View more "sunitinib" in research →

Community Join

0 / 0 results

— no results